Mass testing in Liverpool MISSED ~50% of infections and ~30% with high viral loads. Results are in this Government document, but no actual numbers or details are given.
Absolutely URGENT that @DHSCgovuk reports full data today and HALTS IMPLEMENTATION
STOP USING THESE TESTS FOR PURPOSES WHICH PUT PEOPLE AT RISK. YOUR OWN DATA SAYS IT IS HIGH RISK. MANUFACTURER SAYS DON’T DO IT, WHO SAYS DON’T DO IT, SCIENTISTS SAY DON’T DO. IT IS A MISTAKE.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
@BBCr4today invited me to speak about lateral flow tests this morning (can listen at 0650). All government plans are now about using tests to "release" people - this depends on reliability of negative result. This is what the manufacturer says:
1/16
The PHE Porton Down - Oxford University report included this graph showing sensitivity would be 58% when the test is delivered by a trained test-and-trace centre staff member. This is in symptomatics - not asymptomatics.
2/16
The Government's 77% sensitivity combines the other two groups - tests done by Porton Down lab staff, and tests done by NIHR Research Nurses - i.e. the experts and completely ignores the 58% group. That seems completely wrong.
There are a lot of data and studies reported - difficult to get your head round. Grateful to CI for talking to me this afternoon. He has worked at incredible speed to meet deadlines and says full report is forthcoming – there is more data and description to be added.
2/20
Phase 2 – spiked samples in controlled laboratory conditions
Phase 3a – samples from hospitals tested in controlled laboratory conditions
These do not tell us how well tests work in real world – important to do to move forward to what happens next, but pass by them now.
This is a speculative calculation informed by data available from Liverpool. The source is the Liverpool mayor - reported 23,170 tests done, with 0.7% positive (so about 162) here.
No sensitivity data for this test - @UKPHE has data but not public
I estimate sensitivity of 75% based on independent evaluations done for WHO of other similar LFIA tests (range from 50% to 90%) - but in symptomatic patients
and I presume was on Boris’s list of the tests last night.
We are updating our Cochrane review and have been through our searches. There are no pre-prints or published studies of this test.
There are 2 studies – 1 from the company Instructions for Use (IFU) and 1 from PHE Porton Down.
Test is made by Xiamen Biotime Biotech in China.
Quick Critical appraisal of PHE Porton Down study:
1)Is the study relevant? Can’t tell.
2)What do the results mean? Can’t tell.
3)Should we believe the results? Can’t tell.
(please give us the full report!!!)
2A Test 60 spiked saliva samples (n=15x4 dilutions)+71 -ve samples
2B Test against seasonal coronaviruses
3 Lab study of 1000 negatives and 200 positives sourced by Oxford University Hospitals. -ves fresh (<48hr) saliva samples +ves frozen
“Phase 3 findings will be reported to the Oversight Group, with DHSC and ministers using this information and any recommendations to inform potential purchasing decisions.”
Little detail is public – full results below - criteria for “pass” and “fail” for Phase 3 not stated